Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone
Clinical trial NCT02141087 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT02141087
- Sponsor
- Genentech, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.